INOTEK PHARMACEUTICALS CORP RCKT 5.75 08.01.21
NOTE 5.750% 8/0 · US DOMESTIC · CUSIP 45780VAB8
2
institutional holders
-2 vs Q1 2020
$4.0mprincipal reported held*
$4.4mreported value*
0 new
0 added
0 reduced
2 sold out
net sold ≈ $10.3m
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q2 2020
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 9 |
| Q1 2020 | 4 |
| Q2 2020 | 2 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2020 | 0 | 5 |
| Q2 2020 | 0 | 2 |
Biggest buyers
| None |
Biggest sellers
| WOLVERINE ASSET MANAGEMENT LLC | Sold out | -7.5m |
| Bruce & Co., Inc. | Sold out | -2.0m |
Holders, Q2 2020
| Manager | Shares | Change |
|---|---|---|
| DEUTSCHE BANK AG\ 0.00% of their portfolio | 4.0m $4.4m | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |